Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

New study unravels cause of cognitive loss in tauopathy disorders

Tauopathies are a group of neurodegenerative disorders, including Alzheimer's disease that are characterized by the deposition of aggregates of the tau protein inside brain cells.

13 Oct 2016

Researchers identify how amyloid beta linked to Alzheimer's disease could trigger Parkinson's

Alzheimer's and Parkinson's diseases are different neurodegenerative conditions that can sometimes affect the same person, which has led scientists to investigate possible links between the two.

12 Oct 2016

Symptoms linked to Alzheimer's disease manifest differently in Hispanics, study finds

Certain symptoms associated with the development of Alzheimer's disease, including agitation and depression, affect Hispanics more frequently and severely than other ethnicities.

12 Oct 2016

DHA supplementation enhances cognitive function in older adults with MCI

Results from a recent study published in the Journal of Alzheimer's Disease support the cognitive benefits of DHA, which have been consistently demonstrated with doses of 900 mg/day or greater.

12 Oct 2016

Brain atrophy patterns linked to loss of specific cognitive abilities in patients with Alzheimer's disease

Mathematical modeling of the brain scans of patients with Alzheimer's disease and others at risk for the devastating neurodegenerative disorder has identified specific patterns of brain atrophy that appear to be related to the loss of particular cognitive abilities.

8 Oct 2016

Johns Hopkins researchers identify protein that triggers brain cell death from strokes and injuries

Despite their different triggers, the same molecular chain of events appears to be responsible for brain cell death from strokes, injuries and even such neurodegenerative diseases as Alzheimer's.

7 Oct 2016

New study of Phase II Alzheimer's drug pipeline reveals more ways to combat disease

A new analysis of the Phase II Alzheimer's drug pipeline, conducted by ResearchersAgainstAlzheimer's, revealed 57 new Alzheimer's drugs. According to the analysis, nearly twice as many mechanisms of action are being tested in Phase II than in Phase III clinical trials.

7 Oct 2016

First-ever neuroscience conference to explore ultra-personal approach to brain health

For three days this week, Roanoke, Virginia, is the capital of the precision neuroscience world.

7 Oct 2016

Researchers uncover potential role of gut bacteria in neurodegeneration

Alzheimer's disease (AD), Parkinson's disease (PD) and Amyotrophic Lateral Sclerosis (ALS) are all characterized by clumped, misfolded proteins and inflammation in the brain. In more than 90 percent of cases, physicians and scientists do not know what causes these processes to occur.

6 Oct 2016

Women may have better verbal memory skills than men during early stages of Alzheimer's disease

Women may have better verbal memory skills than men even when their brains show the same level of problems metabolizing glucose, which occurs in people with Alzheimer's disease, according to research published in the October 5, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology.

5 Oct 2016

Researchers develop novel approach to reverse effects of Alzheimer's disease

For the last 20 years, researchers have focused on amyloid beta peptides and the "plaque" they sprout in diseased brains as the main target of Alzheimer's research. But the pace of progress in treating -- not to mention curing -- the debilitating, neurodegenerative disease has been painfully slow.

5 Oct 2016

Professor Illana Gozes from Tel Aviv University receives 2016 RARE Champion of Hope award

Tel Aviv University's Prof. Illana Gozes was awarded the 2016 RARE Champion of Hope -- Science International Prize by Global Genes, a leading global advocacy non-profit organization for patients and families fighting rare and genetic diseases.

5 Oct 2016

Brain rehabilitation via a mobile app? An interview with Keith Cooper

When a person has a brain injury due to a stroke or a trauma, they typically start in a hospital emergency room to treat any life threatening injuries. They are then often transferred to an inpatient rehabilitation program at the hospital where they receive intensive physical and cognitive therapy until they are well enough to transition home.

5 Oct 2016

New study by Alzheimer’s Research UK highlights lack of dementia prevention research

A new study by Alzheimer’s Research UK has highlighted the lack of research into dementia prevention and called for changes to the way risk reduction studies are funded and carried out, in a bid to boost evidence on dementia risk factors.

5 Oct 2016

Fruit flies shed light on how insulin signaling processes may be altered by diabetes in humans

Fruit flies may be small, but the genetic secrets they can unlock for humans are mighty.

4 Oct 2016

Scientists find evidence of link between coronavirus and neurological disease

For the first time, researchers have found proof of a direct association between strain OC 43 of the human coronavirus (HCoV) and neurological disease in humans.

3 Oct 2016

UEF research shows retinal changes may be detected earlier than brain changes

Diseases of the central nervous system (CNS) may manifest as pathological changes in the retina of the eye.

3 Oct 2016

Abnormal protein in the brain may play important role in development of Alzheimer's disease

A recently-recognized pathologic protein in the brain may play a larger role in the development of clinical Alzheimer's disease dementia than previously recognized, according to a study by researchers at Rush University Medical Center.

30 Sep 2016

GUMC receives FDA clearance to begin clinical study of cancer drug in patients with Alzheimer's disease

Georgetown University Medical Center today announces the U.S. Food and Drug Administration has completed its review of an investigational new drug application (IND) for the use of nilotinib in a phase II clinical trial for patients with mild to moderate Alzheimer's disease.

30 Sep 2016

ADDF awards $2.1 million grant for clinical study of cancer drug in Alzheimer's patients

The Alzheimer's Drug Discovery Foundation announces a $2.1 million grant awarded to R. Scott Turner, MD, PhD, of Georgetown University Medical Center to conduct a phase II clinical trial of low-dose nilotinib (marketed as Tasigna for use as a cancer therapy) in patients with Alzheimer's disease.

29 Sep 2016

Alzheimer's Disease News and Research

Further Reading

New study unravels cause of cognitive loss in tauopathy disorders

Researchers identify how amyloid beta linked to Alzheimer's disease could trigger Parkinson's

Symptoms linked to Alzheimer's disease manifest differently in Hispanics, study finds

DHA supplementation enhances cognitive function in older adults with MCI

Brain atrophy patterns linked to loss of specific cognitive abilities in patients with Alzheimer's disease

Johns Hopkins researchers identify protein that triggers brain cell death from strokes and injuries

New study of Phase II Alzheimer's drug pipeline reveals more ways to combat disease

First-ever neuroscience conference to explore ultra-personal approach to brain health

Researchers uncover potential role of gut bacteria in neurodegeneration

Women may have better verbal memory skills than men during early stages of Alzheimer's disease

Researchers develop novel approach to reverse effects of Alzheimer's disease

Professor Illana Gozes from Tel Aviv University receives 2016 RARE Champion of Hope award

Brain rehabilitation via a mobile app? An interview with Keith Cooper

New study by Alzheimer’s Research UK highlights lack of dementia prevention research

Fruit flies shed light on how insulin signaling processes may be altered by diabetes in humans

Scientists find evidence of link between coronavirus and neurological disease

UEF research shows retinal changes may be detected earlier than brain changes

Abnormal protein in the brain may play important role in development of Alzheimer's disease

GUMC receives FDA clearance to begin clinical study of cancer drug in patients with Alzheimer's disease

ADDF awards $2.1 million grant for clinical study of cancer drug in Alzheimer's patients

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News